Apex Biotechnology Debt 2024

Apex Biotechnology Aktienanalyse

What does Apex Biotechnology do?

Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Apex Biotechnology's Debt Structure

Apex Biotechnology's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Apex Biotechnology's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Apex Biotechnology’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Apex Biotechnology’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Apex Biotechnology stock

What is the debt of Apex Biotechnology this year?

Apex Biotechnology has a debt level of -228.65 TWD this year.

What was the debt of Apex Biotechnology compared to the previous year?

The debt of Apex Biotechnology has increased by 51.4% compared to the previous year increased.

What are the consequences of high debt for investors in Apex Biotechnology?

High debt can pose a risk for investors of Apex Biotechnology, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Apex Biotechnology?

Low debt means that Apex Biotechnology has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Apex Biotechnology affect the company?

An increase in debt of Apex Biotechnology can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Apex Biotechnology affect the company?

A reduction in debt of Apex Biotechnology can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Apex Biotechnology?

Some factors that can influence the debt of Apex Biotechnology include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Apex Biotechnology so important for investors?

The debts of Apex Biotechnology are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Apex Biotechnology take to change the debt?

To change the debt, Apex Biotechnology can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Apex Biotechnology pay?

Over the past 12 months, Apex Biotechnology paid a dividend of 1.4 TWD . This corresponds to a dividend yield of about 4.7 %. For the coming 12 months, Apex Biotechnology is expected to pay a dividend of 1.4 TWD.

What is the dividend yield of Apex Biotechnology?

The current dividend yield of Apex Biotechnology is 4.7 %.

When does Apex Biotechnology pay dividends?

Apex Biotechnology pays a quarterly dividend. This is distributed in the months of September, July, July, June.

How secure is the dividend of Apex Biotechnology?

Apex Biotechnology paid dividends every year for the past 21 years.

What is the dividend of Apex Biotechnology?

For the upcoming 12 months, dividends amounting to 1.4 TWD are expected. This corresponds to a dividend yield of 4.7 %.

In which sector is Apex Biotechnology located?

Apex Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apex Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apex Biotechnology from 6/14/2024 amounting to 1.1 TWD, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Apex Biotechnology pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Apex Biotechnology in the year 2023?

In the year 2023, Apex Biotechnology distributed 1.3 TWD as dividends.

In which currency does Apex Biotechnology pay out the dividend?

The dividends of Apex Biotechnology are distributed in TWD.